Image of speaker; Title/Date of presentation
Professional Development

Emerging Therapies in Chronic Kidney Disease in Patients with Type 2 Diabetes

-Identify patients with residual risk for renal and CV events despite optimized standard of care
-Review new agents in CKD with T2D such as SGLT2 inhibitors and non-steroidal MRAs
-Practical considerations when initiating these new therapies

Presenter: Dr. Karthik Tennankore

This group learning has been certified by the College of Family Physicians of Canada and awards 1 Mainpro+ certified credit

Event Details

Jon Allen

Event Cost